Edwards Lifesciences (EW) Has a Deep TAVR Backlog, PT Raised to $130 at Jefferies
Tweet Send to a Friend
Jefferies analyst Anthony Petrone raised the price target on Edwards Lifesciences (NYSE: EW) to $130.00 (from $110.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
